Kathryn Hayashi
Chief Executive Officer at TRIUMF Innovations, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul Geyer | M | 61 |
Nimbus Synergies, Inc.
 Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada.
University of British Columbia
| 13 years |
| Lambert Busque | M | - |
Centre For Commercialization of Cancer Immunotherapy
 Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | - |
| Morgan P. W. Sturdy | M | 71 |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Michael Cross | M | - |
ARTMS, Inc.
 ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | - |
| Paul Schaffer | M | - |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | - |
| Denis Roy | M | - |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | - |
| Jason Robertson | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 7 years |
| Darrell Elliott | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 8 years |
| Thomas English | M | 51 |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Thomas Tradler | M | - |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | - |
| Timothy Smith | M | - |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | - |
| William Brock | M | - |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | - |
| David Porte | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Janet Dancey | M | - |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | - |
| Bernard Massie | M | - |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | - |
| Alfred Sequeira | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Len Ducker | M | - |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | 5 years |
| Christina Schroeder | F | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Merritt Mathew | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 2 years |
| Laura Cassin | F | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 7 years |
| Jason Robertson | - | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 7 years |
| Steven Foster | M | - |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | - |
| Isabelle Riviere | M | - |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | - |
| Steve Hochberg | M | 62 |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | - |
| Michael Jeffrey Abrams | M | 68 |
TRIUMF Innovations, Inc.
 TRIUMF Innovations, Inc. Information Technology ServicesTechnology Services TRIUMF Innovations, Inc. is the business interface and commercialization arm of TRIUMF, Canada's particle accelerator center. The private company is based in Vancouver, Canada. The Canadian company connects TRIUMF to the private sector through industry partnerships, licensing, and company creation. Kathryn Hayashi has been the CEO of the company since 2017. | - |
| Benoît Deschamps | M | 72 |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | - |
| David Main | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Louisa Petropoulos | M | - |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | 8 years |
| Greg Peet | M | 70 |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Michael Ball | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 2 years |
| Yossef Av-Gay | M | 62 |
University of British Columbia
| 30 years |
| James Schlosser | M | - |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | - |
| Karimah Es Sabar | F | 66 |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | 6 years |
| Thomas Francis Gleeson | M | 70 |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | - |
| Daniel Pauly | M | - |
University of British Columbia
| 30 years |
| Angus Livingstone | M | - |
University of British Columbia
| 36 years |
| Amal Khouri | F | - |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | - |
| Louis P. Lacasse | M | 67 |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | - |
| Harrison Nancy | F | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ian Mallmann | M | 63 |
University of British Columbia
| 11 years |
| David A. Nordquist | M | - |
University of British Columbia
| 8 years |
| Gregory Burnett | M | - |
University of British Columbia
| 6 years |
| Mark W. Chu | M | 57 |
University of British Columbia
| 8 years |
| Brett Kagetsu | M | 54 |
University of British Columbia
| 8 years |
| Akio Tanaka | M | 54 |
University of British Columbia
| 6 years |
| Kamran Alam | M | 50 |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada.
University of British Columbia
| 7 years |
| Monica Thornton-Trump | F | - |
University of British Columbia
| 7 years |
| Sebastian Jaimungal | M | - |
University of British Columbia
| 5 years |
| Derek Hemmes | M | - |
University of British Columbia
| 10 years |
| Steve Veitch | M | - |
University of British Columbia
| 5 years |
| Wei Jiong Zhang | M | 71 |
University of British Columbia
| 6 years |
| Andre Marziali | M | - |
University of British Columbia
| 4 years |
| Mary Garden | F | 65 |
University of British Columbia
| 6 years |
| Sanjay Bhanot | M | - |
University of British Columbia
| 7 years |
| Paul Thomas | M | 50 |
University of British Columbia
| 3 years |
| Li Zhu | F | - |
University of British Columbia
| 3 years |
| Michelle Robinson | F | 53 |
University of British Columbia
| 6 years |
| Helge Seetzen | M | - |
University of British Columbia
| 11 years |
| Harrison Cookenboo | M | 65 |
University of British Columbia
| 5 years |
| Patric Ouellette | M | - |
University of British Columbia
| 5 years |
| Wale Bolorunduro | M | - |
University of British Columbia
| 4 years |
| Chun Ning Shih | M | 60 |
University of British Columbia
| 6 years |
| Kong Lok Yip | M | 48 |
University of British Columbia
| 5 years |
| Frank S. Moyle | M | - |
University of British Columbia
| 9 years |
| Dong Xiao Qiu | M | 62 |
University of British Columbia
| 5 years |
| David Bridge | M | - |
University of British Columbia
| 6 years |
| Salim Dhanji | M | 44 |
University of British Columbia
| 8 years |
| John Priatel | M | 58 |
University of British Columbia
| 11 years |
| Nick B. Drake | M | - |
University of British Columbia
| 10 years |
| Timothy Lowinger | M | 60 |
University of British Columbia
| 8 years |
| Peeyush Varshney | M | 57 |
University of British Columbia
| 8 years |
| Ian J. Scott | M | - |
University of British Columbia
| 7 years |
| Bill Hunter | M | 61 |
University of British Columbia
| 4 years |
| Jacqueline Simpson | F | - |
University of British Columbia
| 11 years |
| Robert E. Cohen | M | - |
University of British Columbia
| 11 years |
| Roger Quick | M | - |
University of British Columbia
| 7 years |
| Darrin Erickson | M | - |
University of British Columbia
| 5 years |
| George Gorzynski | M | - |
University of British Columbia
| 4 years |
| Cyndi Laval | F | - |
University of British Columbia
| 4 years |
| Brian Leeners | M | 58 |
University of British Columbia
| 7 years |
| Claire Huxtable | F | - |
University of British Columbia
| 6 years |
| Shaun Foy | M | - |
University of British Columbia
| 9 years |
| Charles Greig | M | - |
University of British Columbia
| 10 years |
| Kurt Loewen | M | 54 |
University of British Columbia
| 6 years |
| William Edward Mufford | M | - |
University of British Columbia
| 6 years |
| Kim Oishi | M | 60 |
University of British Columbia
| 7 years |
| Ying Bin He | M | 62 |
University of British Columbia
| 5 years |
| Andrew Arthur | M | 62 |
University of British Columbia
| 6 years |
| Andrea Zaradic | F | 58 |
University of British Columbia
| 6 years |
| Arie Page | F | 45 |
University of British Columbia
| 8 years |
| Douglas Richardson | M | - |
University of British Columbia
| 6 years |
| Alex Marazzi | M | - |
University of British Columbia
| 8 years |
| Wendi V. Rodrigueza | M | 58 |
University of British Columbia
| 8 years |
| Jonathan Bey | M | 54 |
University of British Columbia
| 5 years |
| Terry Hamilton | M | 61 |
University of British Columbia
| 5 years |
| Trevor Robinson | M | - |
University of British Columbia
| 18 years |
| Tim Hooton | M | - |
University of British Columbia
| 4 years |
| Brian David Game | M | 60 |
University of British Columbia
| 4 years |
| Stephen Kenwood | M | 62 |
University of British Columbia
| 4 years |
| Sheldon Trainor-DeGirolamo | M | 60 |
University of British Columbia
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kathryn Hayashi
- Personal Network
